We would love to hear your thoughts about our site and services, please take our survey here.
Primed got going bust. Investors should have seen these coming. Can only see this getting worse from here.
Napster ... Been watching this fall apart. Well done shorts the company is a mess. BOD are shafting investors unfortunately.
Go
Anyone ever looked at the chart on a monthly seems like Fowler’s running this company to the ground. Sadly can see this going well under placing. Shareholders shafted as always ... chart tells you all you need to know when you zoom out
Is amongst us ... :) Well done to all those have held.. and the excellent research from Riddler
To all the typical loofy comments, when 5p comes knocking on your door don't sit there crying filter this filter that...
There's no need to conversate on this stock everyday all the info needed is out there.
Half the loofs on here bought sold and trying to down play it again ... You carry on with your rince repeats ...
The digging is all done... I see the game who's playing who ain't :)
DMTR will catch people off guard ... GL
......
All you have to do is hold and forget about it, especially the day to day movements... come back when your target is hit... mine is 7p.. for some will be higher and I expect it to do so in good time...
Plenty good notes from Riddler .. Take note of it. And of course DYOR
Key financials:
· Turnover for the Period was £1,311,150, (H1 2019: £1,254,000);
· Gross profit of £302,596, (H1 2019: gross loss £102,000), giving a pre-tax profit of £16,699 after overheads (H1 2019: pre-tax loss: £528,000);
· EPS of 0.00p (H1 2019: (0.11p)); and
· Cash in bank at period end was £405,813 (H1 2019: £27,780); at 9 December 2020 cash at bank was £541,667.
James Dubois, Non-Executive Chairman of Trafalgar, said: 'Your Board is delighted that Trafalgar is today able to report the Company's first period of profitability since 2013. Set against a period of unprecedented volatility and uncertainty in the property sector resulting from the global Covid-19 pandemic, this is a truly commendable performance. With a much stronger Balance Sheet following our June 2020 fund raise and debt conversion, the Company is now able to look forward to the immediate future with a degree of optimism and confidence not felt for a number of years. The board has today sent a circular to shareholders convening an EGM to authorise a share consolidation on a 1 for 10 basis"
Riddlers Notes and a strong reminder
25 Oct '20
#DMTR
Market cap /price £17mln/ 1.8p
Shares in issue : 960mln
Last results : Sept 2020
Revenues: maiden revenues £1mln
Cash at last accounts £2.5mln
Cash raised £2.1mln July 2020 enough till 2023+
= £4mln in cash as of August 2020
Company aim :
Create a shared data cloud where the platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made
Clients include:
Glaxo, Astrazenica , Waters,BASF, Cancer Research Uk, and in July 2020 Novartis and as of Oct 2020 they also gained 5 of the worlds largest pharmacy and agritech.
Major shareholders (top 5) Sept 2020
1 IP group 29.5% and add 50mln of the 140mln new shares
2 Richard Griffiths 8.9%
3 Springer Nature 7%
4Prof Lee Cronin (scientific founder) 6.5% and added 1.2mln
5 Robert Quested 4.9%
Recent developments 2020
*Feb 2020 Chemify ( linked to Cronin lab) part of a grant funded project in:
"Developing a chemical ontology is the first step towards the digitization of chemistry, the UK pharmaceutical market is set to grow from $32B in 2016 to $43B by 2020, with around 5,000 UK companies in the area. In this proposal, we will interact with key companies (Deep Matter and GSK) "
*Astra/Glaxo form part of the Uk government hub with bases in Oxford, Glasgow and others cities.
* Astrazenica had signed an agreement in 2019 work with DMTR to " transform drug design using innovative digital technologies in combination with automation and AI. To get potential new medicines to patients faster"
*Cancer Research at Beatson Glasgow to divert energy to tracking C19 and signed a deal with DMTR on 14th April for:
the sharing of details of their experiments from anywhere and in real-time
A subsequent deployment in China is anticipated to take place later in 2020.
*30th April news that Astra are working on a vaccine( perhaps using DMTR technology) ," AstraZeneca has teamed up with the University of Oxford to develop and manufacture a vaccine for coronavirus, in a move that could allow for rapid vaccination"
*DMTR scientific founder and 7.6% holder Prof. Cronin and the Cronin lab say they cracked the chemical code for the Remdesivir vaccine, in a tweet on 7th April he says "We have written chemical-code (XDL) to robotically make six antiviral drugs (Arbidol; Chloroquine; Favipiravir; Hydroxychloroquine; Remdesivir)
*June : signs collaboration with one of worlds leading companies in the chemicals sector called Waters.
*July working with £200bln valued Novartis
*Sept confirm record revenues and new customers
*Oct :announce they are working with 5 of largest pharmacy and agritech companies
Starts now :)